Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Cohort Dose Escalation Study to Assess the Safety and Efficacy of F-652 in Patients With Alcoholic Hepatitis

NCT02655510 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02655510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02655510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Cohort Dose Escalation Study to Assess the Safety and Efficacy of F-652 in Patients With Alcoholic Hepatitis
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
February 29, 2016
Completion date
June 30, 2018
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic hepatitis